Multiple sclerosis - Emerging concepts of disease pathogenesis

Journal of Neuroimmunology

Volumn 98, Issue 1, 1999, Pages 45-48

  Antel, J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Etiology; Multiple sclerosis; Pathogenesis

Indexed keywords

CARMINIC ACID; CYTOKINE; GADOLINIUM;

CLINICAL FEATURE; CONFERENCE PAPER; DEMYELINATION; HUMAN; MULTIPLE SCLEROSIS; NERVE FIBER DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032984020     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00080-6     Document Type: Conference Paper

References (24)

1. D.L Arnold Magentic resonance spectroscopy: imaging axonal damage in MS J. Neuroimmunol. 98 1999 2 6
2. B Becher P Barker T Owens J Antel CD/95/CD95L: can the brain learn from the immune system? Trends Neurosci. 21 1998 114 117
3. W.F Blakemore H.S Keirstead The origin of remyelinating cells in the central nervous system J. Neuroimmunol. 98 1999 69 76
4. D Bourdette J Antel H McFarland E Montgomery Jr. Monitoring relapsing remitting MS patients J. Neuroimmunol. 98 1999 16 21
5. Charcot, J.M., 1876. Lecture 6: Disseminated sclerosis: pathologic anatomy. In: Lectures on the Diseases of the Nervous System, vol. 1 (G. Sigerson, Trans.). The New Sydenham Society, London, pp. 157–181.
6. Charcot, J.M., 1876. Lecture 7: Disseminated sclerosis: its symptomatology. In: Lectures on the Diseases of the Nervous System, Vol. 1 (G. Sigerson, Trans.). The New Sydenham Society, London, pp. 182–202.
7. N De Stefano P.M Matthew J.P Antel M Preul G Francis D.L Arnold Chemical pathology of acute demyelinating lesions and its correlation with disability Ann. Neurol. 38 1995 901 909
8. K Frei H.P Eugster M Bopst C.S Constantinescu E Lavi A Fontana Tumour necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis J. Exp. Med. 185 12 1997 2177 2182
9. H Heremans C Dillen M Groenen E Martens A Billiau Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma Eur. J. Immunol. 26 10 1996 2393 2398
10. W.E Klinkert K Kojima W Lesslauer W Rinner H Lassmann H Wekerle TNF-alpha receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats: an overview J. Neuroimmunol. 72 2 1997 163 168
11. H Korner F.A Lemckert G Chaudhri S Etteldorf J.D Sedgwick Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system Eur. J. Immunol. 27 8 1997 1973 1981
12. M Krakowski T Owens Interferon-gamma confers resistance to experimental allergic encephalomyelitis Eur. J. Immunol. 26 7 1996 1641 1641
13. U Ladiwala C Lachance S.J.J Simoneau A Bhakar P.A Barker J.P Antel Adult human oligodendrocytes expressing P75 neurotrophin receptor do not undergo apoptosis in response to NGF J. Neurosci. 18 1998 1297 1304
14. D Leppert E Waubant M.R Burk J.R Oksenberg S.L Hauser Interferon beta-1b inhibits gelatinise secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis Ann. Neurol. 40 6 1996 846 852
15. F.D Lublin S.C Reingold Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trial of new agents in multiple sclerosis Neurology 46 4 1996 907 911
16. P.A Narayana T.J Doyle D Lai J.S Wolinsky Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging and quantitative lesion volumetry in multiple sclerosis Ann. Neurol. 43 1 1998 56 71
17. R.M Ransohoff Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines J. Neuroimmunol. 98 1999 57 68
18. J.H Simon From enhancing lesions to brain atrophy in relapsing MS J. Neuroimmunol. 98 1999 7 15
19. O Stuve N.P Dooley J.H Uhm J.P Antel G.S Francis G Williams V.W Yong Interferon beta-1b decreases he migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9 Ann. Neurol. 40 6 1996 853 863
20. P.J Talbot J.S Paquette C Ciurli J.P Antel F Ouellet Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis Ann. Neurol. 39 2 1996 233 240
21. V Taupin T Renno L Bourbonnierre A.C Peterson M Rodriguez T Owens Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system Eur. J. Immunol. 27 4 1997 905 913
22. B.D Trapp L Bö S Mörik A Chang Pathogenesis of tissue injury in MS lesions J. Neuroimmunol. 98 1999 49 56
23. C.L Vanderlugt N.J Karandikar D.J Lenschow M.C Dal Canto J.A Bluestone S.D Miller Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE J. Neuroimmunol. 79 2 1997 113 118
24. E Vowinckel D Reutens B Becher G Verge T Owens J.P Antel PK1195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation multiple sclerosis and EAE J. Neurosci. Res. 50 1997 345 353